The DIAdvisor™ is a large-scale integrating project (IP) aiming at the development of a prediction based tool which uses past and easily available information to optimise the therapy of type I and developed type II diabetes. The DIAdvisor™ is not dependent on specific sensor technologies and can be adapted to technologies like standard strip sensing, minimally-invasive continuous glucose sensors and emerging non-invasive methods.
For safety reason, the DIAdvisor™ system will be able to self-assess the confidence of its proposed decisions. For safety reasons as well as for the sake of therapy improvements, the system connects and provides information and trends to the Health Care Provider.
Glucose prediction is difficult and requires advanced science within the fields of physiological modelling, identification theory, control theory, medical device technology, risk management theory, sensor science and user understanding. It can be achieved only by a well balanced group of eminent experts, including academics, clinicians, user representatives and leading companies.
The expected impact of DIAdvisor™ will be improved diabetes control and quality of life in large populations of insulin treated patients, leading to fewer diabetic complications and lower Health Care costs. Moreover, the project will constitute a valuable opportunity for European companies to build up a special know-how leading to products that profoundly and positively have an impact on the lives of millions of people with other indications than diabetes.